Laman UtamaGLPG • AMS
add
Galapagos NV
Tutup sebelumnya
€24.36
Julat hari
€23.68 - €24.46
Julat tahun
€21.70 - €31.78
Permodalan pasaran
1.56B EUR
Bilangan Purata
110.72K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
AMS
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (EUR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 75.50J | — |
Perbelanjaan pengendalian | 25.29J | — |
Pendapatan bersih | 25.31J | — |
Margin untung bersih | 33.52 | — |
Pendapatan bagi setiap syer | 0.29 | 132.61% |
EBITDA | -53.87J | — |
Kadar cukai berkesan | -0.49% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (EUR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 3.12B | -15.39% |
Jumlah aset | 4.14B | -5.09% |
Jumlah liabiliti | 1.24B | -20.68% |
Jumlah ekuiti | 2.90B | — |
Syer tertunggak | 65.90J | — |
Harga kepada buku | 0.55 | — |
Pulangan pada aset | -3.77% | — |
Pulangan pada modal | -5.42% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (EUR) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 25.31J | — |
Tunai daripada operasi | -59.37J | — |
Tunai daripada pelaburan | 68.36J | — |
Tunai daripada pembiayaan | -1.60J | — |
Perubahan bersih dalam tunai | 8.72J | — |
Aliran tunai bebas | -26.13J | — |
Perihal
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Diasaskan
1999
Tapak web
Pekerja
683
